A Phase la/lb, Open-Label, Multiple-Dose, Dose-Escalation and Expansion Study of the Anti-PD-1 Monoclonal Antibody CS1003 in Subjects with Advanced Solid Tumors

  • Day, Daphne (Primary Chief Investigator (PCI))
  • Markman, Ben (Chief Investigator (CI))

Project: Research

Project Details

StatusFinished
Effective start/end date6/06/19 → 5/06/24

Keywords

  • clinical trial
  • treatment efficacy
  • solid tumours